Current position:Home >Product >
Cyclohexanamine, 4-[[(6-methoxy-4-quinazolinyl)oxy]methyl]-N-(3-phenyl-2-propenyl)-
Cyclohexanamine, 4-[[(6-methoxy-4-quinazolinyl)oxy]methyl]-N-(3-phenyl-2-propenyl)-(683269-27-4)
- Name: Cyclohexanamine, 4-[[(6-methoxy-4-quinazolinyl)oxy]methyl]-N-(3-phenyl-2-propenyl)-
- Synonyms:
- Molecular Formula:C25H29N3O2
- Molecular Weight:
- CAS Registry Number:683269-27-4
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 683266-38-8/3-Cyclopentene-1-carboxylic acid, 3-bromo-1-hydroxy-4-methoxy-2-oxo-, methyl ester
- 683266-79-7/9H-Carbazole-3-carboxaldehyde, 9-[[3-[(methylphenylhydrazono)methyl]-9H-fluoren-9-yl]methyl]-, methylphenylhydrazone
- 683268-88-4/4-Quinolinemethanol, a-[[(3S)-3-[[(2,1,3-benzothiadiazol-5-ylmethyl)amino]methyl]-1-piperidin yl]methyl]-6-methoxy-
- 683268-89-5/4-Quinolinemethanol, a-[[(3S)-3-[[[(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)methyl]amino]meth yl]-1-piperidinyl]methyl]-6-methoxy-
- 683268-95-3/Cyclohexanol, 4-[[3-(2-furanyl)-2-propenyl]amino]-1-[2-(6-methoxy-4-quinazolinyl)ethyl]-
- 683268-98-6/Cyclohexanol, 4-[(1,3-benzodioxol-5-ylmethyl)amino]-1-[2-(6-methoxy-1,5-naphthyridin -4-yl)ethyl]-, cis-
- 683269-00-3/Cyclohexanol, 4-[[(2,3-dihydro-1,4-benzodioxin-6-yl)methyl]amino]-1-[2-(6-methoxy-1,5 -naphthyridin-4-yl)ethyl]-, cis-
- 683269-01-4/2H-1,4-Benzoxazin-3(4H)-one, 6-[[[cis-4-hydroxy-4-[2-(6-methoxy-1,5-naphthyridin-4-yl)ethyl]cyclohexyl] amino]methyl]-
- 683269-06-9/Cyclohexanol, 1-[2-(6-methoxy-4-quinolinyl)ethyl]-4-[(3-phenyl-2-propenyl)amino]-
- 683269-07-0/Cyclohexanol, 1-[2-(6-methoxy-4-quinolinyl)ethyl]-4-[(2-quinoxalinylmethyl)amino]-
- 683269-08-1/1,4-Benzodioxin-5-ol, 2,3-dihydro-6-[[[4-hydroxy-4-[2-(6-methoxy-4-quinolinyl)ethyl]cyclohexyl] amino]methyl]-
- 683269-09-2/Cyclohexanol, 4-[[(2-chloro-3-quinolinyl)methyl]amino]-1-[2-(6-methoxy-4-quinolinyl)eth yl]-
- 683269-12-7/2H-1,4-Benzoxazin-3(4H)-one, 7-[[[4-[2-(6-methoxy-4-quinolinyl)ethyl]cyclohexyl]amino]methyl]-
- 683269-14-9/Cyclohexanol, 4-[[(4-methoxyphenyl)methyl]amino]-1-[2-(6-methoxy-4-quinazolinyl)ethyl ]-
- 683269-15-0/Cyclohexanol, 4-[[(3-fluorophenyl)methyl]amino]-1-[2-(6-methoxy-4-quinazolinyl)ethyl]-
- 683269-22-9/1H-1,4-Diazepine-5-carboxylic acid, hexahydro-1-[2-hydroxy-2-(6-methoxy-4-quinolinyl)ethyl]-4-(2-phenylethyl )-
- 683269-23-0/4-Quinolinemethanol, a-[[hexahydro-5-(hydroxymethyl)-4-(3-phenylpropyl)-1H-1,4-diazepin-1- yl]methyl]-6-methoxy-
- 683269-25-2/2-Quinoxalinemethanamine, N-[4-[[(6-methoxy-4-quinazolinyl)oxy]methyl]cyclohexyl]-
- 683269-26-3/2H-1,4-Benzoxazin-3(4H)-one, 6-[[[4-[[(6-methoxy-4-quinazolinyl)oxy]methyl]cyclohexyl]amino]methyl]-
- 683269-27-4/Cyclohexanamine, 4-[[(6-methoxy-4-quinazolinyl)oxy]methyl]-N-(3-phenyl-2-propenyl)-
- 683269-31-0/2H-1,4-Benzoxazin-3(4H)-one, 6-[[[trans-4-[[(6-methoxy-4-quinolinyl)oxy]methyl]cyclohexyl]amino]methyl ]-
- 683269-34-3/4-Quinolinemethanol, a-[[(3-exo)-3-[[(2,3-dihydro-1,4-benzodioxin-6-yl)methyl]amino]-8-azabi cyclo[3.2.1]oct-8-yl]methyl]-6-methoxy-
- 683269-39-8/4-Quinolinemethanol, a-[[(3-exo)-3-[[3-(2-furanyl)-2-propenyl]amino]-8-azabicyclo[3.2.1]oct-8- yl]methyl]-6-methoxy-
- 683269-40-1/4-Quinolinemethanol, a-[[(3-exo)-3-[(2-benzofuranylmethyl)amino]-8-azabicyclo[3.2.1]oct-8-yl] methyl]-6-methoxy-
- 683269-42-3/4-Quinolinemethanol, a-[[2-[[(1,3-benzodioxol-5-ylmethyl)amino]methyl]-4-morpholinyl]methyl]- 6-methoxy-
- 683269-84-3/Cyclohexanol, 4-[(1,3-benzodioxol-5-ylmethyl)amino]-1-[2-(6-ethoxy-4-quinolinyl)ethyl]-, trans-
- 683269-85-4/Cyclohexanol, 4-[[(2,3-dihydro-1,4-benzodioxin-6-yl)methyl]amino]-1-[2-(6-methoxy-1,5 -naphthyridin-4-yl)ethyl]-, trans-
- 683269-86-5/2H-1,4-Benzoxazin-3(4H)-one, 6-[[[trans-4-hydroxy-4-[2-(6-methoxy-1,5-naphthyridin-4-yl)ethyl]cyclohex yl]amino]methyl]-
- 683269-88-7/2H-1,4-Benzoxazin-3(4H)-one, 6-[[[trans-4-hydroxy-4-[2-(6-methoxy-4-quinolinyl)ethyl]cyclohexyl]amino] methyl]-
- 683269-90-1/Cyclohexanol, 4-[(1,3-benzodioxol-5-ylmethyl)amino]-1-[2-(6-methoxy-1,5-naphthyridin -4-yl)ethyl]-, trans-